GLP-3

GLP-3

GLP-3 is a research peptide currently being investigated for its interaction with GLP-1, GIP, and glucagon receptor pathways. Researchers commonly study GLP-3 in areas involving metabolic regulation, glucose signaling, appetite-related mechanisms, and endocrine research applications.

This product is supplied as a lyophilized powder intended strictly for laboratory research purposes.

GLP-3 (LY3437943) represents a breakthrough in metabolic peptide research, combining three potent mechanisms of action:

 GLP-1 Receptor Agonism – Enhances insulin secretion and satiety
 GIP Receptor Modulation – Improves nutrient partitioning
 Glucagon Receptor Activity – Increases energy expenditure

Why GLP-3 (LY3437943) Outperforms Existing Compounds

Comparative Efficacy Data

Key Research Applications

1. Obesity & Weight Regulation Studies

• Demonstrated 24.2% body weight reduction in primate models (vs 17.5% with semaglutide)
• Targets visceral adipose tissue with 38% greater efficacy than dual agonists

1. Glucose Metabolism Research

• Lowers fasting glucose by 2.1-3.8 mmol/L in diabetic models
• Improves HOMA-IR scores by 62% vs controls

1. Lipid Metabolism Investigations

• Reduces liver fat content by 43-51% in NAFLD models
• Lowers triglycerides by 29% more than GLP-1 mono-agonists

1. Cardiometabolic Protection Studies

• Shows 22% greater CVD risk reduction vs comparators
• Preserves lean mass during weight loss (only 8.3% loss vs 14.1% with diet alone)

Product Specifications

• Compound: GLP-3
• Quantity: 10mg
• Purity: ≥99%
• Appearance: Lyophilized Powder
• Storage: Store in a cool, dry environment away from direct sunlight

Research Disclaimer

This product is intended for laboratory research purposes only. Not for human consumption, medical use, or veterinary use. The statements on this website have not been evaluated by the FDA.